ES2144017T3 - Composicion para el tratamiento externo de la piel. - Google Patents

Composicion para el tratamiento externo de la piel.

Info

Publication number
ES2144017T3
ES2144017T3 ES94108140T ES94108140T ES2144017T3 ES 2144017 T3 ES2144017 T3 ES 2144017T3 ES 94108140 T ES94108140 T ES 94108140T ES 94108140 T ES94108140 T ES 94108140T ES 2144017 T3 ES2144017 T3 ES 2144017T3
Authority
ES
Spain
Prior art keywords
composition
skin treatment
external skin
skin
little
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES94108140T
Other languages
English (en)
Inventor
Fumiaki Nakamura
Yoshimaru Kumano
Kenzo Ito
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shiseido Co Ltd
Original Assignee
Shiseido Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shiseido Co Ltd filed Critical Shiseido Co Ltd
Application granted granted Critical
Publication of ES2144017T3 publication Critical patent/ES2144017T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0212—Face masks
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/765—Polymers containing oxygen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A61K8/345—Alcohols containing more than one hydroxy group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/55—Phosphorus compounds
    • A61K8/553—Phospholipids, e.g. lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/63—Steroids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Emergency Medicine (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)

Abstract

UNA COMPOSICION PARA EL TRATAMIENTO EXTERNO DE LA PIEL QUE CONTIENE ERITRITOL, LECITINA HIDROGENADA Y UN DERIVADO DEL COLESTEROL AL QUE SE AÑADE POLIOXIETILENO QUE ES EXCELENTE PARA PREVENIR Y MEJORAR LA ASPEREZA DE LA PIEL, DEJA POCA SENSACION DE SER PEGAJOSO, SE ABSORBE RAPIDAMENTE EN LA PIEL Y TIENE UN EFECTO DE ABLANDAMIENTO DE LOS CALLOS EXCELENTE.
ES94108140T 1994-05-02 1994-05-26 Composicion para el tratamiento externo de la piel. Expired - Lifetime ES2144017T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP09350094A JP3344822B2 (ja) 1994-05-02 1994-05-02 皮膚外用剤

Publications (1)

Publication Number Publication Date
ES2144017T3 true ES2144017T3 (es) 2000-06-01

Family

ID=14084075

Family Applications (1)

Application Number Title Priority Date Filing Date
ES94108140T Expired - Lifetime ES2144017T3 (es) 1994-05-02 1994-05-26 Composicion para el tratamiento externo de la piel.

Country Status (5)

Country Link
US (1) US5753242A (es)
EP (1) EP0612513B1 (es)
JP (1) JP3344822B2 (es)
DE (2) DE69423805T2 (es)
ES (1) ES2144017T3 (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19537027A1 (de) * 1995-10-05 1997-04-10 Beiersdorf Ag Hautpflegemittel für alte Haut
USH2013H1 (en) * 1997-05-23 2002-02-05 The Procter & Gamble Company Skin care compositions
EP0943324A3 (en) * 1998-03-17 2002-01-02 Shiseido Company, Ltd. External skin treatment composition
JP3557544B2 (ja) * 1998-05-15 2004-08-25 株式会社コーセー 角質柔軟化粧料
TWI266639B (en) * 1998-11-13 2006-11-21 Ajinomoto Kk Weak acid skin cleanser
US6995297B1 (en) * 1999-07-13 2006-02-07 Deuk Hun Ahn Herb medicine composition to be contained in sanitary materials for infants
JP2002265347A (ja) * 2001-03-13 2002-09-18 Shiseido Co Ltd コーニファイドエンベロープの成熟を促す化粧料
KR100465976B1 (ko) * 2002-01-05 2005-01-13 주식회사 태평양 나노유화기술에 의해 진세노사이드 ｆ1을 함유하는 미세 유화 입자 및 이를 사용한 피부 외용제 조성물
US20040213821A1 (en) * 2003-01-31 2004-10-28 The Procter & Gamble Company Skin care composition comprising first and second emulsions
US20050238598A1 (en) * 2004-04-07 2005-10-27 Lionnel Aubert Antiperspirant compositions and method comprising wax microparticles
JP5101808B2 (ja) * 2004-09-16 2012-12-19 株式会社コーセー 水中油型液状組成物
US7258079B2 (en) * 2005-10-17 2007-08-21 Ken Foster Apparatus and method for waterproofing game birds
DE102006035040A1 (de) * 2006-07-28 2008-01-31 Beiersdorf Ag Wirkstoffkombinationen aus Ascorbylverbindung und hydriertem Lecithin
FR2927801B1 (fr) 2008-02-22 2010-03-05 Sederma Sa Composition cosmetique hydratante comprenant une combinaison d'homarine et d'erythritol
ES2400246T3 (es) * 2008-03-10 2013-04-08 The Procter & Gamble Company Composición cosmética
KR101889327B1 (ko) * 2014-12-31 2018-09-20 (주)아모레퍼시픽 다양한 유화 입자 사이즈를 함유하는 혼성 유화 조성물 및 그 제조방법

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58121209A (ja) * 1982-01-11 1983-07-19 Eisai Co Ltd 乳化型外用組成物
IT1193614B (it) * 1983-01-24 1988-07-21 Crinos Industria Farmaco Preparato per l'igiene e la pulizia della pelle del cuoio capelluto e dei capelli
WO1988000572A1 (fr) * 1986-07-24 1988-01-28 Shiseido Company Ltd. Poudre spherique d'argile minerale, son procede de production et composition la contenant
EP0349150B1 (en) * 1988-06-20 1994-08-17 Shiseido Company Limited Transparent compostition
WO1990001323A1 (en) * 1988-08-12 1990-02-22 Bernstein Joel E Method and composition for treating and preventing dry skin disorders
JP2866114B2 (ja) * 1989-09-20 1999-03-08 株式会社資生堂 化粧料
US5221796A (en) * 1991-02-12 1993-06-22 Fuji Photo Film Co., Ltd. Glycerol derivatives
US5310555A (en) * 1992-07-24 1994-05-10 Midwestern Bio-Ag Products And Services, Inc. Oral nutritional and dietary composition

Also Published As

Publication number Publication date
EP0612513A3 (en) 1995-12-06
EP0612513B1 (en) 2000-04-05
US5753242A (en) 1998-05-19
EP0612513A2 (en) 1994-08-31
JPH07300408A (ja) 1995-11-14
DE612513T1 (de) 1995-03-16
DE69423805D1 (de) 2000-05-11
DE69423805T2 (de) 2001-01-25
JP3344822B2 (ja) 2002-11-18

Similar Documents

Publication Publication Date Title
UY24354A1 (es) Composiciones farmacéuticas que contienen epinastina
SE9601421D0 (sv) New composition
ES2172242T3 (es) Composiciones oftalmicas de liberacion mantenida conteniendo medicamentos solubles en agua.
PT100963A (pt) Composicoes farmaceuticas para aplicacao topica de elevada penetracao atraves da pele que compreendem certos polimeros nao-ionicos especificos
ES2165441T3 (es) Inhibidores de calpaina y/o catepsina b oxazolidin sustituidos.
ES2120274T3 (es) Utilizacion de un extracto de una bacteria filamentosa no fotosintetica y composicion.
ES2160640T3 (es) Nuevos (r)-5-carbamoil-8-fluoro-3-amino disustituido en n,n-3,4-dihidro-2h-1-benzopiranos.
BR0113286A (pt) Pirazóis substituìdos
ES2179096T3 (es) Utilizacion de la interleucina-12 para prevenir la reaccion del injerto contra el huesped.
ES2194999T3 (es) Composicion para el tratamiento de heridas.
UA70925C2 (uk) Спосіб лікування естрогенстимульованого раку
BR9509006A (pt) Composiçao para aplicaçao tópica na pele composiçao farmacêutica uso de um inibidor de síntese de colesterol e processo para o tratamento mitigaçao ou prevençao de distúrbios de pele
AR006401A1 (es) Compuestos de pirrolopirrolona, una composicion farmaceutica que los contiene, su uso en la fabricacion de un medicamento y en terapia, procesospara su preparación y compuestos intermediarios para dichos procesos.
MX9707636A (es) Ascomicinas.
AR012193A1 (es) Nuevas combinaciones terapeuticas
AR020781A1 (es) Uso de composicion oftalmica
ES2170143T3 (es) Composiciones que comprenden halofantrina en una forma especial.
ES2071131T3 (es) Di- y tetra-fluor analogos de escualeno como inhibidores de escualeno epoxidasa.
AR023511A1 (es) Composicion que comprende (s) y (r) 5-amino-3-ciano-1-(2,6-dicloro-4-trifluorometilfenil)-4-trifluoro-metilsulfinilpirazol, dichos compuestos aislados y usos de los mismos como plaguicida
BR9915955A (pt) Composição cosmética para cuidado com a pele, processo cosmético para tratar uma pele envelhecida e uso de 4- cromanona
AR012546A1 (es) Utilizacion de al menos un compuesto seleccionado entre el grupo que comprende los sogaoles y los gingeroles para la preparacion de una composiciondesodorante, sogaol, extracto bruto y extracto purificado que contiene el sogaol y la composicion desodorante obtenida.
ES2145234T3 (es) Derivados de la diosmetina, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
ES2172558T3 (es) Lubricante compatible con radiaciones para dispositivos medicos.
AR019327A1 (es) Combinacion de fentolamina y apomorfina para el tratamiento de la funcion y disfuncion sexual humana
BR9802803A (pt) ação e composições farmacêuticas contendo os mesmos.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 612513

Country of ref document: ES